Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OLIVER: SBRT for Liver Oligometastases in Colorectal Cancer
NCT03532204Withdrawn
- Sponsor
- Unicancer
- Start
- Apr 2019
- Primary completion
- Dec 2021
01
Overview
Randomised, open-label trial in colorectal cancer (CRC) and liver metastases (2 arms), sponsored by Unicancer. Primary endpoint: Progression Free Survival at 1 year. Planned start Apr 2019; status: withdrawn.
02
Conditions
colorectal cancer (CRC)liver metastases
Beyond the preview
Go deeper on NCT03532204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03532204.